In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

Impact of BRCA1 gene alterations on tumor characteristics and clinical outcome in ovarian cancer (OC) patients. Background: Advanced ovarian clear cell carcinomas (OCCCs) are notoriously drug ...

Semi-quantitative protein analysis of HER2 and ER levels in human breast cancer reveals broad expression ranges within HER2+ and ER+ phenotypes No significant financial relationships to disclose. This ...

DUBLIN--(BUSINESS WIRE)--The "China Microarray Market Size, Share, Forecast, & Trend Analysis by Product, Application, End User- Forecast to 2031" report has been added to ResearchAndMarkets.com's ...

It is now becoming generally recognized that microarray technology will be a fundamental tool used in future genomics research. As the technology becomes more widely accessible, larger numbers of ...

The Geniom® RT Analyzer, a new benchtop microarray processing instrument, was presented by febit at Select Bioscience’s “Advances in Microarray Technology”. The platform complements Geniom® One, the ...

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...

CPT codes for OGM are key components for obtaining reimbursement from third party payers when labs use LDTs based on OGM as alternatives to legacy cytogenetics methods such as karyotyping, ...

Protein microarrays are many things to many people. Like the more mature DNA “chips”, they are often patterns of tiny spots arrayed on a microscope-type slide, used to determine the makeup and amount ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (BNGO), announced that Centers for Medicare & Medicaid Services, CMS, posted ...